Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05360914 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hospital at Home for Elderly Acute Ill Patients

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Eligibility criteria expanded, about 11 words
    • Study description expanded, about 11 words
    v3
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Aug 2024 to Aug 2027
    • Study sites: 0 to 3
    • Start date changed from estimate of Jun 2022 to Jun 1, 2022
    v2
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Many elderly patients with uncomplicated treatment courses are admitted unnecessarily, which is a burden for the patient and society. Studies show that Hospital at Home (HaH) treatment is an alternative to hospitalization. The patient's risk of delirium, infection and loss of function is reduced when the patient avoids the hospital stay. HaH treatment is expected to be more cost-effective, improve patients' functional abilities and patients' satisfaction. Three municipalities, general practitioners, pre-hospital service and an emergency department (ED) in Central Denmark Region have organized the first HaH treatment model across disciplines and sectors. Specialists in the ED and the municipal acute teams provide HaH treatment for elderly acute ill patients. However, the model has not yet been evaluated. The aim of this study is to optimize the HaH treatment model for elderly acute ill patients. The objective is to increase patient satisfaction and optimize the use of resources in healthcare by avoiding unnecessary hospitalizations that impair and prolong treatment. This study is an open label randomized controlled trial (RCT) with a 1:2 allocation ratio of acute hospital admission versus HaH. During a pilot period, we tested and adapted the patient pathway of HaH to the practical reality, before we start the randomization for the RCT study. We will investigate the clinical effects and health economic consequences of HaH treatment compared with standard hospital treatment.
Trial Details
NCT Number NCT05360914
Lead Sponsor Defactum, Central Denmark Region
Collaborators: Interdisciplinary Centre for Organizational Architecture (ICOA), Aarhus University, Denmark, Research Center for Emergency Medicine, Aarhus University, Denmark, Viborg Regional Hospital
Conditions
(from sponsor)
Cystitis, Erysipelas, Pneumonia
Related terms Cystitis, Erysipelas, Pneumonia
Enrollment 849 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov